Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bharat Starch is a prominent Indian manufacturer and exporter of maize-based starch and its derivatives, primarily serving the pharmaceutical, food, and industrial sectors. The company specializes in producing high-quality excipients, including pharmaceutical-grade maize starch, liquid glucose, dextrose monohydrate, and sorbitol. These products are essential in drug formulation, serving as binders, disintegrants, and sweeteners for tablets, capsules, and liquid orals. Bharat Starch operates manufacturing facilities that adhere to stringent quality control measures to ensure compliance with international pharmacopeial standards such as USP, BP, and IP. By maintaining a robust supply chain and export network, the company supports global healthcare manufacturing by providing reliable and high-purity ingredients. Its role is centered on the supply of critical raw materials rather than direct drug discovery or clinical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bharat Starch.